IT201600127037A1 - Soluzione oftalmica di verde di lissamina e suo uso in oftalmologia - Google Patents

Soluzione oftalmica di verde di lissamina e suo uso in oftalmologia

Info

Publication number
IT201600127037A1
IT201600127037A1 IT102016000127037A IT201600127037A IT201600127037A1 IT 201600127037 A1 IT201600127037 A1 IT 201600127037A1 IT 102016000127037 A IT102016000127037 A IT 102016000127037A IT 201600127037 A IT201600127037 A IT 201600127037A IT 201600127037 A1 IT201600127037 A1 IT 201600127037A1
Authority
IT
Italy
Prior art keywords
lissamina
ophthalmology
green
ophthalmic solution
ophthalmic
Prior art date
Application number
IT102016000127037A
Other languages
English (en)
Inventor
Stefano Barabino
Gianluca Magozzi
Original Assignee
Oftalab S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oftalab S R L filed Critical Oftalab S R L
Priority to IT102016000127037A priority Critical patent/IT201600127037A1/it
Priority to US16/469,662 priority patent/US20200009270A1/en
Priority to JP2019531702A priority patent/JP7296316B2/ja
Priority to PCT/IB2017/057935 priority patent/WO2018109704A1/en
Priority to PT178292918T priority patent/PT3554476T/pt
Priority to ES17829291T priority patent/ES2922254T3/es
Priority to EP17829291.8A priority patent/EP3554476B1/en
Priority to PL17829291.8T priority patent/PL3554476T3/pl
Publication of IT201600127037A1 publication Critical patent/IT201600127037A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0071—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form solution, solute
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology
    • G01N2800/162—Conjunctival disorders, e.g. conjunctivitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Optics & Photonics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IT102016000127037A 2016-12-15 2016-12-15 Soluzione oftalmica di verde di lissamina e suo uso in oftalmologia IT201600127037A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT102016000127037A IT201600127037A1 (it) 2016-12-15 2016-12-15 Soluzione oftalmica di verde di lissamina e suo uso in oftalmologia
US16/469,662 US20200009270A1 (en) 2016-12-15 2017-12-14 Ophthalmic solution of lissamine green and its use in ophthalmology
JP2019531702A JP7296316B2 (ja) 2016-12-15 2017-12-14 リサミングリーンの点眼液、及び眼科学におけるその使用
PCT/IB2017/057935 WO2018109704A1 (en) 2016-12-15 2017-12-14 Ophthalmic solution of lissamine green and its use in ophthalmology
PT178292918T PT3554476T (pt) 2016-12-15 2017-12-14 Solução oftálmica de verde lissamina e o seu uso em oftalmologia
ES17829291T ES2922254T3 (es) 2016-12-15 2017-12-14 Solución oftalmática de verde de lisamina y su uso en oftalmología
EP17829291.8A EP3554476B1 (en) 2016-12-15 2017-12-14 Ophthalmic solution of lissamine green and its use in ophthalmology
PL17829291.8T PL3554476T3 (pl) 2016-12-15 2017-12-14 Okulistyczny roztwór zieleni lizaminowej i jego zastosowanie w okulistyce

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102016000127037A IT201600127037A1 (it) 2016-12-15 2016-12-15 Soluzione oftalmica di verde di lissamina e suo uso in oftalmologia

Publications (1)

Publication Number Publication Date
IT201600127037A1 true IT201600127037A1 (it) 2018-06-15

Family

ID=58545098

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102016000127037A IT201600127037A1 (it) 2016-12-15 2016-12-15 Soluzione oftalmica di verde di lissamina e suo uso in oftalmologia

Country Status (8)

Country Link
US (1) US20200009270A1 (it)
EP (1) EP3554476B1 (it)
JP (1) JP7296316B2 (it)
ES (1) ES2922254T3 (it)
IT (1) IT201600127037A1 (it)
PL (1) PL3554476T3 (it)
PT (1) PT3554476T (it)
WO (1) WO2018109704A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112336877A (zh) * 2020-11-09 2021-02-09 天津晶明新技术开发有限公司 一种用于眼表染色的染色液及其制备方法
CN114642743B (zh) * 2020-12-21 2024-06-14 天津晶明新技术开发有限公司 用于眼表组织染色的染色剂滴眼液

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103301478A (zh) * 2012-03-14 2013-09-18 天津晶明新技术开发有限公司 一种新的混合型角结膜活体染色剂
WO2014098888A1 (en) * 2012-12-21 2014-06-26 Colgate-Palmolive Company Controlled delivery whitening compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218428B1 (en) * 2000-04-28 2001-04-17 Emil Chynn Ophthalmic composition
JP2009522596A (ja) 2005-12-29 2009-06-11 ジョンソン・アンド・ジョンソン・ビジョン・ケア・インコーポレイテッド 界面活性剤を用いて、シリコーンヒドロゲルの眼科用レンズを離型させるための方法およびシステム
US20110257186A1 (en) 2010-04-15 2011-10-20 Staubli Ursula V Compositions and methods for treating visual disorders
AU2014212275B2 (en) 2013-02-01 2018-09-06 Ocuphire Pharma, Inc. Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103301478A (zh) * 2012-03-14 2013-09-18 天津晶明新技术开发有限公司 一种新的混合型角结膜活体染色剂
WO2014098888A1 (en) * 2012-12-21 2014-06-26 Colgate-Palmolive Company Controlled delivery whitening compositions

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRON A J ET AL: "Clinical staining of the ocular surface: Mechanisms and interpretations", PROGRESS IN RETINAL AND EYE RESEARCH, OXFORD, GB, vol. 44, 23 October 2014 (2014-10-23), pages 36 - 61, XP029115577, ISSN: 1350-9462, DOI: 10.1016/J.PRETEYERES.2014.10.001 *
GORRINGE ET AL: "Lissamine green as a protein stain in paper electrophoresis", CLINICA CHIMICA ACTA, ELSEVIER BV, AMSTERDAM, NL, vol. 2, no. 5, 1 October 1957 (1957-10-01), pages 353 - 371, XP025848643, ISSN: 0009-8981, [retrieved on 19571001], DOI: 10.1016/0009-8981(57)90031-1 *

Also Published As

Publication number Publication date
US20200009270A1 (en) 2020-01-09
EP3554476B1 (en) 2022-04-13
PT3554476T (pt) 2022-07-12
ES2922254T3 (es) 2022-09-12
JP2020503290A (ja) 2020-01-30
EP3554476A1 (en) 2019-10-23
JP7296316B2 (ja) 2023-06-22
PL3554476T3 (pl) 2022-08-08
WO2018109704A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
CL2016002364A1 (es) Indazol-3-carboxamidas 5-sustituidas y preparación y uso de las mismas
BR112017024899A2 (pt) proteínas de ligação trispecíficas e métodos de uso.
DK3641819T3 (da) Anvendelse af cannabidiol i behandling af tuberøst sklerosekompleks
BR112016015706A2 (pt) composto, uso do mesmo e composição farmacêutica
BR112016025787A2 (pt) Formulação farmacêutica compreendendo gencitabina-[fenil- (benzóxi-l-alaninil)]-fosfato, seu uso no tratamento de câncer, método de preparação e kit compreendendo a mesma
SMT201600069B (it) Composizioni comprendenti 15-hepe e metodi d’uso delle stesse
DK3143011T3 (da) Deutererede heterocykliske forbindelser og deres anvendelse som billeddannende stoffer
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3395353T3 (da) Plasminogen til anvendelse til behandling eller forebyggelse af diabetes-mellitus-nerveskade
DK3532067T3 (da) Liposomal formulering til anvendelse til behandling af cancer
BR112016020889A2 (pt) variantes de hppd e métodos de uso
CR20180296A (es) ANTICUERPOS ANTI-HtrA1 Y MÉTODOS DE USO
DK3094322T3 (da) Administration af tasimelteon i fastende tilstand
DK3325618T3 (da) Hidtil ukendte trypsin-isoformer og anvendelse deraf
CL2015002110A1 (es) Parvovirus porcino 5b, métodos de uso y vacuna
CL2015000537A1 (es) Siarn y su uso en los métodos y composiciones para el tratamiento y/o prevención de enfermedades de los ojos.
ITUA20162425A1 (it) Composizione oftalmica che comprende PVP-I
ES2897983T8 (es) Liposomas cargados con IPA-3 y procedimientos de uso de los mismos
ITUB20160543A1 (it) Composizione oftalmica stabilizzante e reintegrante del film lacrimale per uso nella prevenzione delle infezioni virali
ITUA20161706A1 (it) Nuovi coloranti cumarinici e relativi coniugati
IT201600127037A1 (it) Soluzione oftalmica di verde di lissamina e suo uso in oftalmologia
DK3452093T3 (da) Ophthalmiske sammensætninger
DK3423042T3 (da) Lyofiliseret farmaceutisk formulering og anvendelse deraf
MA47844A (fr) Combinaison comprenant du palmitoyléthanolamide (pea) et du e lycopène pour utilisation dans le traitement de maladies inflammatoires